Royce & Associates LP Omnicell, Inc Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
A detailed history of Royce & Associates LP transactions in Omnicell, Inc stock. As of the latest transaction made, Royce & Associates LP holds 19,417 shares of OMCL stock, worth $601,150. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,417
Previous 18,597
4.41%
Holding current value
$601,150
Previous $810,000
6.54%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding OMCL
# of Institutions
295Shares Held
45.1MCall Options Held
858KPut Options Held
75.6K-
Black Rock Inc. New York, NY8.18MShares$253 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.56MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA2.24MShares$69.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.64MShares$50.9 Million0.02% of portfolio
-
Lazard Asset Management LLC New York, NY1.64MShares$50.8 Million0.12% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $1.37B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...